Fried Robert N — SEC Form 4 filings

SEC reporting owner CIK 1417952. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-02-23 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Niagen Bioscience, Inc. (NAGE)Chief Executive Officer, Director79

Form 4 filings — Fried Robert N

FiledFormIssuerReported transactionsSource
2026-07-084Niagen Bioscience, Inc. (NAGE)Grant/award (A): 1,106 @ $2.71EDGAR
2026-04-274Niagen Bioscience, Inc. (NAGE)Option exercise (M): 20,000 @ $2.61 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-02-244Niagen Bioscience, Inc. (NAGE)Grant/award (A): 503,937 (derivative) @ $0EDGAR
2025-04-094Niagen Bioscience, Inc. (NAGE)Option exercise (M): 66,667 @ $3.30 · Option exercise (M): 66,667 (derivative) @ $0EDGAR
2025-02-274ChromaDex Corp. (CDXC)Grant/award (A): 1,518,600 (derivative) @ $0EDGAR
2025-02-144ChromaDex Corp. (CDXC)Grant/award (A): 492,278 (derivative) @ $0EDGAR
2024-02-234ChromaDex Corp. (CDXC)Grant/award (A): 399,568 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1417952 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →